Bavarian Nordic CEO Paul Chaplin warns US pharma reshoring could take 5-10 years, citing tech transfer complexities. Company ...

Novo Nordisk cut the price of its weight loss blockbuster Wegovy by nearly two-thirds for certain patients paying outside of ...

A UK startup that wants to bring protein degraders to the neurodegeneration field has closed a $31 million seed round.

Fulcrum Therapeutics loses a partner, Tenax raises money for expanded trials, and Celon Pharma’s Phase 2 Parkinson’s data.

BioNTech has paused an early-stage study of its experimental malaria vaccine after the FDA handed it a clinical hold, the ...

Trump’s NIH nom­i­nee Jayan­ta “Jay” Bhat­tacharya goes be­fore a Sen­ate com­mit­tee on Wednes­day to like­ly face tough ...

Jazz Pharmaceuticals will buy North Carolina biotech Chimerix for $935 million in cash, the companies said Wednesday morning.

Bayer said Wednesday its pharmaceuticals unit will likely see a decline in sales in 2025 as the company reported another set ...

Eli Lilly opens unprecedented public submission process for US states to pitch potential manufacturing sites as part of $27B ...

Persica Pharmaceuticals reports positive Phase 1b results for PP353, a two-dose antibiotic combining linezolid and iohexol, ...

BeiGene's Tevimbra approved for ESCC with chemo, Tenaya plans $52.5M offering, Evotec gets $20M from Bristol Myers Squibb, and Osivax raises €10M for flu vaccine research ...

Edenbridge Pharmaceuticals received this year's first untitled letter from the FDA's drug promotion office over misleading ...